Our work suggests that homozygous variants in FGF4 may lead to a phenotype of thoracic abnormalities with respiratory insufficiency, which could prompt screening of other rare disease cohorts, or inclusion in diagnostic testing panels. This evidence concerns the gene FGF4 and Respiratory insufficiency.